The Physicians of Retina-Vitreous Center
All Retina-Vitreous Center physicians are Board Certified and fellowship trained in vitreoretinal disease and are members of the following medical socieites:
Collectively, the physicians have published dozens of scientific articles in the field of ophthalmology and retina, and have participated in several national eye research studies, including the following:
-
Pneumatic Retinopexy Study
- Treatment of retinal detachment with intraocular gas
-
Endophthalmitis Vitrectomy Study
- Antibiotic treatment of post cataract surgery intraocular infection
-
Complications of Age-Related Macular Degeneration Prevention Trial (CAPT) 
-
Vitrase Study
- Treatment of vitreous hemorrhage with an intraocular injection
-
Miravant Study
- Photodynamic therapy for the treatment of macular degeneration
-
Lilly Protein Kinase C ß Inhibitor Trial
- An oral medication for the treatment of diabetic retinopathy.
-
Genentech rhuFab (Lucentis) Trial
- Treatment of wet macular degeneration with intraocular injections of the study drug
-
Basal Laminar Drusen Study
- A natural history study of patients with a particular form of macular degeneration characterized by basal laminar drusen
-
Anecortave Acetate (Retaane) Study
- Treatment of wet macular degeneration with periocular injections of the study drug
-
Vista Trial
- Treatment of wet macular degeneration with a combination of intraocular steroids and Visudyne photodynamic therapy
A current special interest of the practice is the in-office repair of retinal detachment.
The physicians actively participate in the teaching program at Robert Wood Johnson Medical School, where Dr. Stuart N. Green serves as Chairman of the Department of Ophthalmology. In cooperation with the clinical research staff at the Medical School, Retina-Vitreous Center provides ophthalmic and retinal support for the many ongoing clinical trials.
|
